Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial

Table 1

Patient baseline demographics (PP, perprotocol analysis).

Patient baseline demographics	Tailored triple therapy with placebo ()	Probiotic before tailored triple therapy ()	Probiotic before and after tailored Triple therapy ()	value
Male/female ()	48/50	49/48	50/47	0.71
Mean age (years)	46.2	55.9	34.1	0.92
Mean follow-up time, (day)	33 ± 4	35 ± 2	34 ± 3	0.98
Mutation pattern
(i) Wild type A2143/2142A (susceptible)	23	21	24	0.18
(ii) Mutation, A2143/2142CG (resistance)	15	18	12	0.14
(iii) Mixed wild type + mutation, A2143/A2142GC; (Susceptible + resistance)	60	58	61	0.23